Home > Insider Trading > Filing (0001179110-14-002617)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1586105	Egalet Corp	EGLT	Pharmaceutical Preparations (2834)	463575334

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1591617	Renee Aguiar-Lucander	460 East Swedesford Road Suite 1050 Wayne PA 19087		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-02-11	60,000	$0.00	60,000	No	4	X	Indirect	By Omega Fund IV
Common Stock	Acquisiton	2014-02-11	171,241	$6.00	231,241	No	4	C	Indirect	By Omega Fund IV
Common Stock	Acquisiton	2014-02-11	83,333	$12.00	314,574	No	4	P	Indirect	By Omega Fund IV

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Indirect	By Omega Fund IV
No	4	C	Indirect	By Omega Fund IV
No	4	P	Indirect	By Omega Fund IV

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants	Disposition	2014-02-11	60,000	$0.00	60,000	$0.00
Common Stock	Senior Convertible Debt	Disposition	2014-02-11	0	$0.00	171,241	$6.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	X	Indirect
0			No	4	C	Indirect

Footnotes

The reporting person is Omega Fund IV L.P. ("Omega Fund IV"). Omega Fund IV GP, L.P. ("Omega GP") is the general partner of Omega, and Omega Fund IV GP Manager, Ltd. ("Omega Manager") is the general partner of Omega GP. Ms. Aguiar-Lucander is a director of Omega Manager and therefore may be deemed to share the right to direct the voting and dispositive control of shares held by Omega Fund IV. Ms. Aguiar-Lucander disclaims beneficial ownership of any such securities except to the extent of his proportionate pecuniary interest therein, and this report shall not be deemed an admission that Ms. Aguiar-Lucander is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
The warrants were automatically exercised into Egalet Corporation common stock immediately prior to the consummation of the Egalet Corporation's initial public offering on a 1-for-1 basis, pursuant to the Omega Fund IV's purchase of a specified minimum amount of common stock in such offering.
The senior convertible debt automatically converted into Egalet Corporation common stock immediately prior to the consummation of Egalet Corporation's initial public offering, based on a conversion price equal to 50% of the per share price in such offering, which was $12 per share.